chrX-70063118-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_207320.3(OTUD6A):c.594C>T(p.Phe198=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0041 in 1,209,759 control chromosomes in the GnomAD database, including 18 homozygotes. There are 1,617 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0043 ( 4 hom., 134 hem., cov: 23)
Exomes 𝑓: 0.0041 ( 14 hom. 1483 hem. )
Consequence
OTUD6A
NM_207320.3 synonymous
NM_207320.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.128
Genes affected
OTUD6A (HGNC:32312): (OTU deubiquitinase 6A) Deubiquitinating enzymes (DUBs; see MIM 603478) are proteases that specifically cleave ubiquitin (MIM 191339) linkages, negating the action of ubiquitin ligases. DUBA2 belongs to a DUB subfamily characterized by an ovarian tumor (OTU) domain.[supplied by OMIM, May 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-70063118-C-T is Benign according to our data. Variant chrX-70063118-C-T is described in ClinVar as [Benign]. Clinvar id is 777743.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.128 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00408 (4475/1097876) while in subpopulation MID AF= 0.0268 (111/4137). AF 95% confidence interval is 0.0228. There are 14 homozygotes in gnomad4_exome. There are 1483 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTUD6A | NM_207320.3 | c.594C>T | p.Phe198= | synonymous_variant | 1/1 | ENST00000338352.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTUD6A | ENST00000338352.3 | c.594C>T | p.Phe198= | synonymous_variant | 1/1 | NM_207320.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00436 AC: 488AN: 111831Hom.: 4 Cov.: 23 AF XY: 0.00400 AC XY: 136AN XY: 33979
GnomAD3 genomes
AF:
AC:
488
AN:
111831
Hom.:
Cov.:
23
AF XY:
AC XY:
136
AN XY:
33979
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00405 AC: 740AN: 182743Hom.: 3 AF XY: 0.00398 AC XY: 268AN XY: 67353
GnomAD3 exomes
AF:
AC:
740
AN:
182743
Hom.:
AF XY:
AC XY:
268
AN XY:
67353
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00408 AC: 4475AN: 1097876Hom.: 14 Cov.: 31 AF XY: 0.00408 AC XY: 1483AN XY: 363286
GnomAD4 exome
AF:
AC:
4475
AN:
1097876
Hom.:
Cov.:
31
AF XY:
AC XY:
1483
AN XY:
363286
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00432 AC: 483AN: 111883Hom.: 4 Cov.: 23 AF XY: 0.00394 AC XY: 134AN XY: 34041
GnomAD4 genome
AF:
AC:
483
AN:
111883
Hom.:
Cov.:
23
AF XY:
AC XY:
134
AN XY:
34041
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 17, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at